AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10374221 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-androgen treatment
Number of subjects: 93
Study 8679349 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 64
Study 8679349 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 64
Study 1905372 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (45 days) plus Rifampin (21 days)
Number of subjects: 84
Study 1905372 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline (45 days) plus Streptomycin (14 days)
Number of subjects: 84
Study 6345023 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery (group 1)
Number of subjects: 100
Study 6345023 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy (group 2)
Number of subjects: 100
Study 30192210 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-Based Cardiac Telerehabilitation (HBCTR)
Number of subjects: 80
Study 30192210 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 80
Study 29023310 — intervention group
Group type: EXPERIMENTAL
Intervention: Lid-Parallel Conjunctival Folds (LIPCOF)
Number of subjects: 148
Study 29023310 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive break-up time (NIKBUT)
Number of subjects: 148
Study 26086328 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 20
Study 26086328 — intervention group
Group type: COMPARATOR
Intervention: Liberal sodium diet
Number of subjects: 20
Study 23540718 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 262
Study 21248633 — intervention group
Group type: EXPERIMENTAL
Intervention: Pylorus-resecting pancreatoduodenectomy (PrPD)
Number of subjects: 130
Study 21248633 — intervention group
Group type: COMPARATOR
Intervention: Pylorus-preserving pancreatoduodenectomy (PpPD)
Number of subjects: 130
Study 18325516 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing doses of E(2) from days 3 to 5 (group 1)
Number of subjects: 21
Study 18325516 — intervention group
Group type: COMPARATOR
Intervention: No hormonal treatment (group 2)
Number of subjects: 21
Study 18325516 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing doses of E(2) for 15 days (group 3)
Number of subjects: 21
Study 17190528 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant and nonstimulant medications
Number of subjects: 0
Study 17190528 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting medications
Number of subjects: 0
Study 17190528 — intervention group
Group type: EXPERIMENTAL
Intervention: Negotiated trial of time off treatment
Number of subjects: 0
Study 15548275 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Core/New Bond (Kuraray)
Number of subjects: 50
Study 15548275 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilink (Vivadent)
Number of subjects: 50
Study 15548275 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia 21/ED Primer (Kuraray)
Number of subjects: 50
Study 15548275 — intervention group
Group type: EXPERIMENTAL
Intervention: PermaFlo DC (Ultradent)
Number of subjects: 50
Study 15548275 — intervention group
Group type: EXPERIMENTAL
Intervention: Variolink II/Excite DSC (Vivadent)
Number of subjects: 50
Study 11574353 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 30
Study 11574353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9752283 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (Gra) 1 mg
Number of subjects: 188
Study 9752283 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (Ond) 8 mg
Number of subjects: 188
Study 7583864 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol xinafoate 50 micrograms bid via Diskhaler
Number of subjects: 210
Study 7583864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 2195102 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg of triazolam
Number of subjects: 11
Study 2195102 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg of triazolam
Number of subjects: 11
Study 2195102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 748488 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone cream applied twice a day for five days
Number of subjects: 0
Study 748488 — intervention group
Group type: COMPARATOR
Intervention: Inert carrier base applied twice a day for five days
Number of subjects: 0
Study 31714801 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagonally aligned sitting training on a tilted surface (10° backward and down toward the most affected side)
Number of subjects: 33
Study 31714801 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagonally aligned sitting training on a tilted surface
Number of subjects: 33
Study 31714801 — intervention group
Group type: COMPARATOR
Intervention: Control group (horizontal surface)
Number of subjects: 33
Study 30266266 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider Success narrative
Number of subjects: 280
Study 30266266 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider Bias narrative
Number of subjects: 280
Study 30266266 — intervention group
Group type: COMPARATOR
Intervention: Non-narrative Control
Number of subjects: 280
Study 25869603 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight/obese children
Number of subjects: 185
Study 22976445 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program using the prosthesis simulator for 5 days
Number of subjects: 48
Study 22976445 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 48
Study 22470019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground-roasted peanuts without skin (GRPWS)
Number of subjects: 13
Study 22470019 — intervention group
Group type: COMPARATOR
Intervention: Raw peanuts with skin (RPS)
Number of subjects: 13
Study 22470019 — intervention group
Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 13
Study 22470019 — intervention group
Group type: COMPARATOR
Intervention: Roasted peanuts without skin
Number of subjects: 13
Study 20716911 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g of creatine (Cr)
Number of subjects: 18
Study 20716911 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 18
Study 16485230 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler imaging (CDI) in normal pressure glaucoma patients
Number of subjects: 30
Study 16485230 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 30
Study 15231367 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (16 mg for 4 weeks tapered to 4 mg for 4 months)
Number of subjects: 104
Study 15231367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 10646895 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine treatment
Number of subjects: 0
Study 10646895 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine treatment in tumour-bearing mice
Number of subjects: 0
Study 8958001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.66 g ethanol/kg orally followed by 0.1 g ethanol/kg per h intravenously)
Number of subjects: 10
Study 8958001 — intervention group
Group type: COMPARATOR
Intervention: Control (identical volumes of oral water and intravenous saline)
Number of subjects: 10
Study 1579252 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 MIU rt-PA
Number of subjects: 31
Study 1579252 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 MIU rt-PA
Number of subjects: 31
Study 1579252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 4014185 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewer-administered questionnaire
Number of subjects: 0
Study 4014185 — intervention group
Group type: COMPARATOR
Intervention: Self-administered questionnaire
Number of subjects: 0
Study 4014185 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical and cigarette smoking variables
Number of subjects: 0
Study 4014185 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet histories
Number of subjects: 0
Study 4014185 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects and spouses
Number of subjects: 0
Study 30366687 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity simulation platform and 8-week curriculum of independent practice of aortic and coronary anastomosis
Number of subjects: 29
Study 30366687 — intervention group
Group type: COMPARATOR
Intervention: Usual operative experience (Control)
Number of subjects: 29
Study 28776134 — intervention group
Group type: EXPERIMENTAL
Intervention: Superelastic shape‐memory alloy (SNT) rod
Number of subjects: 24
Study 28776134 — intervention group
Group type: COMPARATOR
Intervention: Conventional titanium alloy (CTA) rod
Number of subjects: 24
Study 26948697 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIRIT‐HF
Number of subjects: 29
Study 26948697 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 29
Study 23412948 — intervention group
Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) prevention system
Number of subjects: 4407
Study 22231921 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins B(1) + B(6) (n=6)
Number of subjects: 31
Study 22231921 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B(6) (n=11)
Number of subjects: 31
Study 20061883 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel intervention based on the ecological model, implemented over a 2-year period with worksite-wide events and employee-based advisory boards.
Number of subjects: 34
Study 20061883 — intervention group
Group type: COMPARATOR
Intervention: Comparison condition (control group)
Number of subjects: 34
Study 17350190 — intervention group
Group type: EXPERIMENTAL
Intervention: Perimenopausal health education intervention
Number of subjects: 335
Study 17350190 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 335
Study 15635606 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airways pressure (CPAP) for 24 hours
Number of subjects: 97
Study 15635606 — intervention group
Group type: COMPARATOR
Intervention: Headbox oxygen
Number of subjects: 97
Study 15635606 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airways pressure (CPAP)
Number of subjects: 97
Study 12150176 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA patch
Number of subjects: 165
Study 12150176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 9860036 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate 200 microg once daily
Number of subjects: 21
Study 9860036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 8589159 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime (8 mg/[kg.d]; maximum 400 mg) once a day for 4 days
Number of subjects: 131
Study 8589159 — intervention group
Group type: COMPARATOR
Intervention: Rifampin (20 mg/kg; maximum, 600 mg) once a day for 4 days
Number of subjects: 131
Study 2283715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir granules at a dose of 3 mg/kg
Number of subjects: 42
Study 2283715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir granules at a dose of 6 mg/kg
Number of subjects: 42
Study 2283715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir granules at daily doses of 9.0‐20.7 mg/kg in 3 divided portions
Number of subjects: 42
Study 2283715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir granules
Number of subjects: 42
Study 10249191 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention in the form of a mothers' group discussion led by the clinic social worker
Number of subjects: 201
Study 10249191 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 201
Study 31768618 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin tuck against resistance (CTAR)
Number of subjects: 36
Study 31768618 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin tuck exercise with theraband
Number of subjects: 36
Study 31768618 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaker exercises
Number of subjects: 36
Study 31768618 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 36
Study 31510721 — intervention group
Group type: COMPARATOR
Intervention: Bilateral PC6 sham injection of 0.9% sodium chloride + intravenous granisetron (Group A, n=31)
Number of subjects: 94
Study 31510721 — intervention group
Group type: COMPARATOR
Intervention: Bilateral acupuncture point injection at PC6 of 0.9% sodium chloride + intravenous 0.9% sodium chloride (Group B, n=33)
Number of subjects: 94
Study 31510721 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral acupuncture point injection at PC6 of 0.9% sodium chloride + intravenous granisetron (Group C, n=30)
Number of subjects: 94
Study 31510721 — intervention group
Group type: COMPARATOR
Intervention: Comparison of motilin concentration after 12 hours in all groups
Number of subjects: 94
Study 31510721 — intervention group
Group type: COMPARATOR
Intervention: Comparison of time for first anal exsufflation in all groups
Number of subjects: 94
Study 28266871 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Dry Needling (DDN)
Number of subjects: 133
Study 28266871 — intervention group
Group type: COMPARATOR
Intervention: Manual Palpation (MPal)
Number of subjects: 133
Study 25890480 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellular immunotherapy (CIT) with autologous natural killer cells, γδT cells, and cytokine‐induced killer cells in combination with chemotherapy
Number of subjects: 58
Study 25890480 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellular immunotherapy (CIT) with chemotherapy
Number of subjects: 58
Study 25890480 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 58
Study 23487517 — intervention group
Group type: EXPERIMENTAL
Intervention: Betrixaban 40 mg once daily
Number of subjects: 508
Study 23487517 — intervention group
Group type: EXPERIMENTAL
Intervention: Betrixaban 60 mg once daily
Number of subjects: 508
Study 23487517 — intervention group
Group type: EXPERIMENTAL
Intervention: Betrixaban 80 mg once daily
Number of subjects: 508
Study 23487517 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (adjusted to INR 2.0-3.0)
Number of subjects: 508
Study 21328090 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically managed withdrawal
Number of subjects: 344
Study 19414675 — intervention group
Group type: EXPERIMENTAL
Intervention: mitumprotimut-T/GM-CSF
Number of subjects: 349
Study 19414675 — intervention group
Group type: COMPARATOR
Intervention: placebo/GM-CSF
Number of subjects: 349
Study 17049237 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue of hip movers (frontal and sagittal planes)
Number of subjects: 20
Study 17049237 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue of frontal movers
Number of subjects: 20
Study 17049237 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue of lower extremity muscle groups (ankle plantar/dorsi flexors, ankle evertor/invertors, hip flexor/extensors, hip abductor/adductors)
Number of subjects: 20
Study 15119683 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal mucosal grafts
Number of subjects: 0
Study 15119683 — intervention group
Group type: COMPARATOR
Intervention: Dura mater grafts
Number of subjects: 0
Study 15119683 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia lata grafts
Number of subjects: 0
Study 11436934 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-only intervention
Number of subjects: 335
Study 11436934 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic plus a school-as-community (SAC) component
Number of subjects: 335
Study 11436934 — intervention group
Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 335
Study 9596465 — intervention group
Group type: EXPERIMENTAL
Intervention: Dictation in the presence of the patient
Number of subjects: 120
Study 9596465 — intervention group
Group type: COMPARATOR
Intervention: Standard visit control group
Number of subjects: 120
Study 8191242 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil 100 mg bid for 5 days (n = 113)
Number of subjects: 220
Study 8191242 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin 600 mg tid for 10 days (n = 107)
Number of subjects: 220
Study 8191242 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil
Number of subjects: 220
Study 8191242 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin
Number of subjects: 220
Study 3312761 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic hemodiafiltration (H HDF)
Number of subjects: 10
Study 3312761 — intervention group
Group type: COMPARATOR
Intervention: Hemodialysis (HD)
Number of subjects: 10
Study 29793869 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥85th percentile (overweight or obese)
Number of subjects: 388
Study 29793869 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥95th percentile (obese)
Number of subjects: 388
Study 29793869 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher body fat (subscapular skinfold and triceps skinfold >85th percentile)
Number of subjects: 388
Study 29793869 — intervention group
Group type: EXPERIMENTAL
Intervention: Central fat (waist circumference >90th percentile)
Number of subjects: 388
Study 29793869 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary activity levels
Number of subjects: 388
Study 29793869 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic and/or diastolic hypertension
Number of subjects: 388
Study 29793869 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdischarge weight gain velocities from 36 weeks postmenstrual age to 18 months
Number of subjects: 388
Study 29793869 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain velocity from 18 months to 6‐7 years
Number of subjects: 388
Study 27780285 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bundle all‐inside arthroscopic inlay
Number of subjects: 20
Study 27780285 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bundle all‐inside suspensory fixation
Number of subjects: 20
Study 27780285 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bundle arthroscopic‐assisted open onlay (SB‐ONL)
Number of subjects: 20
Study 27780285 — intervention group
Group type: EXPERIMENTAL
Intervention: Double bundle arthroscopic‐assisted open inlay (DB‐INL)
Number of subjects: 20
Study 27780285 — intervention group
Group type: EXPERIMENTAL
Intervention: Double bundle all‐inside suspensory fixation (DB‐SUSP)
Number of subjects: 20
Study 27780285 — intervention group
Group type: COMPARATOR
Intervention: PCL intact
Number of subjects: 20
Study 26156743 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary folate intake (tertile 3 compared with tertile 1)
Number of subjects: 5880
Study 26156743 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte folate concentration (tertile 3 compared with tertile 1)
Number of subjects: 5880
Study 23117470 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium-iron-phosphate-citrate complex
Number of subjects: 51
Study 23117470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 20884982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty (137 patients)
Number of subjects: 252
Study 20884982 — intervention group
Group type: COMPARATOR
Intervention: Cemented total hip replacement (THR) (115 patients)
Number of subjects: 252
Study 18579449 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs that mentioned 'randomization' in the title or abstract
Number of subjects: 142
Study 18579449 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs that described the method to generate the random sequence
Number of subjects: 142
Study 18579449 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs with adequate allocation concealment
Number of subjects: 142
Study 18579449 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs that mentioned 'masking'
Number of subjects: 142
Study 18579449 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality RCTs as assessed by the Jadad scale
Number of subjects: 142
Study 18579449 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall reporting quality of RCTs
Number of subjects: 142
Study 15699226 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Breakfast (EB)
Number of subjects: 10
Study 15699226 — intervention group
Group type: COMPARATOR
Intervention: Omitting Breakfast (OB)
Number of subjects: 10
Study 12855349 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream and oral glucose (1 ml of glucose at 300 mg/ml)
Number of subjects: 90
Study 12855349 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream and oral glucose
Number of subjects: 90
Study 12855349 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream and water
Number of subjects: 90
Study 10100592 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron injection (40 microg/kg) via 30-min infusion
Number of subjects: 93
Study 10100592 — intervention group
Group type: COMPARATOR
Intervention: Granisetron injection (40 microg/kg) via slow intravenous injection over 30 s
Number of subjects: 93
Study 10100592 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron injection (40 microg/kg) via 30-min infusion and slow intravenous injection
Number of subjects: 93
Study 8739815 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen withheld (hypoxaemia)
Number of subjects: 10
Study 8739815 — intervention group
Group type: COMPARATOR
Intervention: Supplemental oxygen administered (normoxaemia)
Number of subjects: 10
Study 8739815 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxaemia (PaO2 < or = 50 Torr)
Number of subjects: 10
Study 8739815 — intervention group
Group type: COMPARATOR
Intervention: Normoxaemia (PaO2 > or = 60 Torr)
Number of subjects: 10
Study 8739815 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxaemia
Number of subjects: 10
Study 8739815 — intervention group
Group type: COMPARATOR
Intervention: Normoxaemia
Number of subjects: 10
Study 1911498 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 9
Study 1911498 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 9
Study 7134874 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:3 jejunoileal bypass
Number of subjects: 34
Study 7134874 — intervention group
Group type: COMPARATOR
Intervention: 3:1 jejunoileal bypass
Number of subjects: 34